NewJour Home |
NewJour: N |
Search
[Subject Prev] [Subject Next]
NATAP Reports (National AIDS Treatment Advocacy Project)
-
Sender: owner-newjour@ccat.sas.upenn.edu
Forwarded message:
Date: Tue, 3 Mar 1998 07:29:36 +0100
From: Michael Uwe Moebius <m.moebius@uni-koeln.de>
Subject: NATAP Reports (National AIDS Treatment Advocacy Project)
NATAP Reports (National AIDS Treatment Advocacy Project)
http://www.natap.org
The National AIDS Treatment Advocacy Project - NATAP - provides the latest
in HIV and AIDS drug development, research, and treatment information (on
topics such as protease inhibitors, nucleosides, non-nucleosides, and
double protease combinations). NATAP's newletter, our New Protease
Inhibitor User's Guide, as well as in-depth articles on HIV and AIDS
treatments, and other publications are all available on this site.J We
also provide comprehensive reports from the Fifth Retroviruses and
Opportunistic Infections conference, as well as from the ICAR, ICAAC,
IDSA, European and International HIV and AIDS conferences, and from other
sources.
NATAP is committed to providing the most comprehensive and real-time
up-to-date treatment information available. When there are advances in
AIDS treatment we will publish them either in our newsletter or on our web
site.
A subscription to NATAP Reports will allow you to receive a copy of the
newsletter. All our publications are free for those who cannot afford to
pay; however, we do appreciate a suggested donation for subscriptions.
NATAP is a 501(c)-3 non-profit corporation, so donations are
tax-deductible.
Individual Subscription: $25.00
Institutional/Physician/Corporate: $75
Low-Income Subscription: any amount
Issues 1, 2 and 3/4 of volume 1 can be found on their homepage. They are
available in html and pdf format.
email: info@natap.org
NewJour Home |
NewJour: N |
Search
[Subject Prev] [Subject Next]